PHAT: Phathom Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PHAT: Phathom Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 286.21
Enterprise Value ($M) 543.39
Book Value ($M) -253.58
Book Value / Share -3.64
Price / Book -1.13
NCAV ($M) -271.76
NCAV / Share -3.90
Price / NCAV -1.05

Profitability (mra)
Return on Invested Capital (ROIC) -1.11
Return on Assets (ROA) -0.94
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.16
Current Ratio 4.20

Balance Sheet (mrq) ($M)
Current Assets 360.13
Assets 378.32
Liabilities 631.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 55.25
Operating Income -277.47
Net Income -334.33

Cash Flow Statement (mra) ($M)
Cash From Operations -266.77
Cash from Investing -0.14
Cash from Financing 182.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G BlackRock, Inc. 5.20 0.00
11-05 13G/A Prudential Financial Inc 11.00
11-04 13G Jennison Associates Llc 10.40
08-22 13D/A Frazier Life Sciences Public Fund, L.P. 18.00 25.75
2024-04-10 13D/A Takeda Pharmaceutical Co Ltd 4.80 -11.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-06-14 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-06-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 290,858 1,209,261 24.05
2025-04-10 282,423 1,166,637 24.21
2025-04-09 140,762 1,064,193 13.23
2025-04-08 224,728 822,910 27.31
2025-04-07 139,869 706,811 19.79

(click for more detail)

Similar Companies
PCVX – Vaxcyte, Inc. PEPG – PepGen Inc.
PGEN – Precigen, Inc. PHVS – Pharvaris N.V.
PLRX – Pliant Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io